DuPont Announces Collaboration with Microsoft and NobleAI to Accelerate R&D Innovation with AI

WILMINGTON, Del., Nov. 12, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced a collaboration with Microsoft and NobleAI to expand access to advanced AI tools and resources, including machine learning that helps its scientists and engineers innovate faster. The collaboration is designed to support DuPont's innovation by reducing cycle times for delivering customer solutions.

The collaboration brings together DuPont's deep advanced solutions and application expertise; NobleAI's Science-Based AI modeling capabilities, powered by its Visualizations, Insights and Predictions (VIP) Platform; and Microsoft Discovery, Microsoft's enterprise agentic AI platform for R&D. It aims to help DuPont innovators and engineers evaluate potential solutions more rapidly, guide experimentation, and accelerate cycles of learning.

"Our AI and innovation strategy is rooted in giving our scientists and engineers the capabilities and resources to solve the world's most challenging problems and enable customers to move at today's pace," said Marty DeGroot, DuPont Chief Technology Officer. "By combining our R&D experience and expertise with NobleAI's advanced modeling capabilities, and Microsoft's agentic AI platform, we are expanding access to digital innovation tools that will help our teams accelerate development, shorten time to market and expand the impact of innovation across our portfolio."

"For AI to create lasting value, it has to be built on a foundation the enterprise can trust," said Matt Abbott, DuPont Chief Information Officer. "This collaboration reflects how we are scaling AI at DuPont, with security and governance designed in from the start, so what proves out in one lab can be put to work across the company."

"DuPont's researchers are working on so many high-value customer problems, and our Science-Based AI can help them fast-track solutions," said Alex Wang, CEO of NobleAI. "Microsoft Discovery gives scientists an agentic platform to plan and orchestrate their research, and NobleAI's VIP Platform powers the scientific modeling that predicts and optimizes. Together, DuPont's teams can build on the data and expertise they have today, within the workflows they already use, to explore far more ideas in silico, through computer simulation, so physical testing goes to the candidates most worth pursuing."

"Breakthroughs happen when deep scientific expertise meets the right tools," said Aseem Datar, Corporate Vice President of Product Innovation for Microsoft Discovery & Quantum. "Microsoft Discovery gives R&D teams an agentic AI platform purpose-built for scientific discovery, connecting their data, models and know-how so they can explore more possibilities with confidence and rigor. By combining DuPont's advanced solutions leadership with NobleAI's science-based modeling, we're helping bring new ideas from the lab to the market faster."

About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

About NobleAI
NobleAI delivers practical, Science-Based AI solutions for energy, chemistry and manufacturing companies. Its proprietary modeling technology integrates scientific principles throughout the AI modeling workflow to help organizations accelerate discovery, improve predictions, and make better R&D decisions. The Visualizations, Insights and Predictions (VIP) Platform turns limited industrial data into predictive models organizations can act on, helping them evaluate more options in software before committing to physical testing. As one of the first launch partners for Microsoft Discovery, Microsoft's agentic AI platform for scientific R&D, NobleAI brings advanced scientific modeling into agentic workflows for industrial research and development. Backed by investments from M12 and Chevron Technology Ventures, NobleAI helps global enterprises make faster, higher-confidence decisions that turn science into revenue. For more information about NobleAI, visit noble.ai.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. © 2026 DuPont.

Cautionary Statement Regarding Forward-looking Statements
Certain statements in this document may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "may", "could", "project", "estimate", "forecast" and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.

Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) the ability to realize the intended benefits of the Electronics Separation and the Qnity Distribution, including achievement of the intended tax treatment and the contractual allocation to, and assumption by, Qnity of liabilities and obligations, including certain legacy liabilities, as well as the possibility of disputes, litigation or unanticipated costs in connection with the Electronics Separation and Qnity Distribution; (ii) the impact of the Aramids Divestiture on DuPont's balance sheet, financial condition and future results of operations, as well as any post-closing adjustments, and disputes or unanticipated costs in connection with the Aramids Divestiture; (iii) risks and costs associated with per- and polyfluoroalkyl substances ("PFAS") and the related arrangement among DuPont, Corteva, Inc. and The Chemours Company to share certain eligible costs, including the outcome of pending or future litigation, which includes personal injury claims and natural resource damages claims; the extent and cost of ongoing or future remediation and other environmental obligations; the collectability or availability of indemnification, reimbursement or cost-sharing rights; and applicable changes in laws, regulations, or enforcement policies; (iv) the failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with completed and future, if any, divestitures, mergers, acquisitions and other portfolio-management, productivity and infrastructure actions; (v) risks and uncertainties outside the Company's control that adversely affect the economic and operating environment in which DuPont, its customers and/or its suppliers operate, including inflationary or deflationary pressures, changes in interest rates, foreign currency exchange rates, credit availability, consumer and industrial demand, economic slowdowns or recessions, political and regulatory developments, international trade policies, geopolitical tensions and military conflicts, capital market volatility as well as pandemics, natural disasters, severe weather events and other disruptions; (vi) the availability and cost of raw materials, energy, transportation and logistics, including the Company's ability to mitigate or offset cost increases, shortages, delays or other supply-chain disruptions through pricing, productivity initiatives, alternative sourcing or otherwise; (vii) risks and uncertainties associated with continuing or expanding geopolitical conflicts, trade disputes, sanctions, trade restrictions and responsive or retaliatory actions, including the imposition, modification, invalidation, reinstatement or replacement of tariffs, export controls, including on exports to China of U.S.-regulated products and technology, or other trade measures; (viii) other risks to DuPont's business and operations, including cybersecurity, operational and impairment risks; (ix) risks and uncertainties associated with the timing, amount and completion of repurchases under the Company's share repurchase authorization, including market conditions, the trading price of the Company's common stock, alternative uses of capital, applicable legal requirements, associated costs and the possibility that repurchases may be reduced, suspended or discontinued prior to completion; (x) the effects of the Reverse Stock Split on the trading price, liquidity and marketability of the Company's common stock and the Company's ability to realize the intended benefits of the Reverse Stock Split; and (xi) other risk factors discussed in DuPont's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with the U.S. Securities and Exchange Commission.

Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

SOURCE DuPont